Laser-Assisted Removal of Embedded Vena Cava Filters: A First-In-Human Escalation Trial in 500 Patients Refractory to High-Force Retrieval
William T Kuo, Ankur A Doshi, John M Ponting, Jarrett K Rosenberg, Tie Liang, Lawrence V Hofmann, William T Kuo, Ankur A Doshi, John M Ponting, Jarrett K Rosenberg, Tie Liang, Lawrence V Hofmann
Abstract
Background Many patients are subject to potential risks and filter-related morbidity when standard retrieval methods fail. We evaluated the safety and efficacy of the laser sheath technique for removing embedded inferior vena cava filters. Methods and Results Over an 8.5-year period, 500 patients were prospectively enrolled in an institutional review board-approved study. There were 225 men and 275 women (mean age, 49 years; range, 15-90 years). Indications for retrieval included symptomatic acute inferior vena cava thrombosis, chronic inferior vena cava occlusion, and/or pain from filter penetration. Retrieval was also offered to prevent risks from prolonged implantation and potentially to eliminate need for lifelong anticoagulation. After retrieval failed using 3X standard retrieval force (6-7 lb via digital gauge), treatment escalation was attempted using laser sheath powered by 308-nm XeCl excimer laser system (CVX-300; Spectranetics). We hypothesized that the laser-assisted technique would allow retrieval of >95% of embedded filters with <5% risk of major complications and with lower force. Primary outcome was successful retrieval. Primary safety outcome was any major procedure-related complication. Laser-assisted retrieval was successful in 99.4% of cases (497/500) (95% CI, 98.3%-99.9%) and significantly >95% (P<0.0001). The mean filter dwell time was 1528 days (range, 37-10 047; >27.5 years]), among retrievable-type (n=414) and permanent-type (n=86) filters. The average force during failed attempts without laser was 6.4 versus 3.6 lb during laser-assisted retrievals (P<0.0001). The major complication rate was 2.0% (10/500) (95% CI, 1.0%-3.6%), significantly <5% (P<0.0005), 0.6% (3/500) (95% CI, 0%-1.3%) from laser, and all were successfully treated. Successful retrieval allowed cessation of anticoagulation in 98.7% (77/78) (95% CI, 93.1%-100.0%) and alleviated filter-related morbidity in 98.5% (138/140) (95% CI, 96.5%-100.0%). Conclusions The excimer laser sheath technique is safe and effective for removing embedded inferior vena cava filters refractory to high-force retrieval. This technique may allow cessation of filter-related anticoagulation and can be used to prevent and alleviate filter-related morbidity. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT01158482.
Keywords: IVC filter; endovascular; filter retrieval; laser.
Conflict of interest statement
None.
Figures
References
- Kuo WT, Robertson SW, Odegaard JI, Hofmann LV. Complex retrieval of fractured, embedded, and penetrating inferior vena cava filters: a prospective study with histologic and electron microscopic analysis. J Vasc Interv Radiol. 2013;24:622–630.
- Jia Z, Wu A, Tam M, Spain J, McKinney JM, Wang W. Caval penetration by inferior vena cava filters: a systematic literature review of clinical significance and management. Circulation. 2015;132:944–952.
- The PREPIC Study Group . Eight‐year follow‐up of patients with permanent vena cava filters in the prevention of pulmonary embolism. the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112:416–422.
- Hajduk B, Tomkowski WZ, Malek G, Davidson BL. Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: a prospective, observational cohort study. Chest. 2010;137:877–882.
- Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Excimer laser‐assisted removal of embedded IVC filters: a single‐center prospective study. Circ Cardiovasc Interv. 2013;6:560–566.
- Food and Drug Administration . Removing inferior vena cava filters: FDA safety communication. Posted online May 6, 2014. . Accessed September 1, 2020.
- Al‐Hakim R, Kee ST, Olinger K, Lee EW, Moriarty JM, McWilliams JP. Inferior vena cava filter retrieval: effectiveness and complications of routine and advanced techniques. J Vasc Interv Radiol. 2014;25:933–939.
- Desai KR, Laws JL, Salem R, Mouli SK, Errea MF, Karp JK, Yang Y, Ryu RK, Lewandowski RJ. Defining prolonged dwell time: when are advanced inferior vena cava filter retrieval techniques necessary? Circ Cardiovasc Interv. 2017;10:e003957. doi:10.1161/CIRCINTERVENTIONS.116.003957
- Tavri S, Patel IJ, Kavali P, Irani Z, Ganguli S, Walker TG. Endobronchial forceps‐assisted complex retrieval of inferior vena cava filters. J Vasc Surg Venous Lymphat Disord. 2019;7:413–419.
- Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Laser‐assisted removal of embedded vena cava filters: a 5‐year first‐in‐human study. Chest. 2017;151:417–424.
- Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–S202.
- De Gregorio MA, Gamboa P, Bonilla DL, Sanchez M, Higuera MT, Medrano J, Mainar A, Lostalé F, Laborda A. Retrieval of Günther‐Tulip optional vena cava filters 30 days after implantation: a prospective clinical study. J Vasc Interv Radiol. 2006;17:1781–1789.
- Bikdeli B, Chatterjee S, Desai NR, Kirtane AJ, Desai MM, Bracken MB, Spencer FA, Monreal M, Goldhaber SZ, Krumholz HM. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta‐analysis. J Am Coll Cardiol. 2017;70:1587–1597.
- Wang SL, Lloyd AJ. Clinical review: inferior vena cava filters in the age of patient‐centered outcomes. Ann Med. 2013;45:474–481.
- Reddy S, Lakhter V, Zack CJ, Zhao H, Chatterjee S, Bashir R. Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration advisory. JAMA Intern Med. 2017;177:1373–1374.
- Gaspard SF, Gaspard DJ. Retrievable inferior vena cava filters are rarely removed. Am Surg. 2009;75:426–428.
- Sarosiek S, Crowther M, Sloan JM. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med. 2013;173:513–517.
- Duszak R Jr, Parker L, Levin DC, Rao VM. Placement and removal of inferior vena cava filters: national trends in the Medicare population. J Am Coll Radiol. 2011;8:483–489.
- Food and Drug Administration . Inferior vena cava (IVC) filters: initial communication: risk of adverse events with long term use. Posted online August 9, 2010. . Accessed September 1, 2020.
- Bikdeli B, Kirtane AJ, Jimenez D, Green P, Spencer FA, Kuo WT, Krumholz HM, Parikh SA. Hemopericardium and cardiac tamponade as a complication of vena caval filters: systematic review of the published literature and the MAUDE database. Clin Appl Thromb Hemost. 2019;25:1076029619849111.
Source: PubMed